DK144306C - Grundmasse til anvendelse ved fremstilling af en farmaceutiskenhedsdosis med langsom frigoerelse af en aktiv bestanddel samt fremgangsmaade til fremstilling deraf - Google Patents

Grundmasse til anvendelse ved fremstilling af en farmaceutiskenhedsdosis med langsom frigoerelse af en aktiv bestanddel samt fremgangsmaade til fremstilling deraf

Info

Publication number
DK144306C
DK144306C DK277372A DK277372A DK144306C DK 144306 C DK144306 C DK 144306C DK 277372 A DK277372 A DK 277372A DK 277372 A DK277372 A DK 277372A DK 144306 C DK144306 C DK 144306C
Authority
DK
Denmark
Prior art keywords
procedures
basic
producing
preparation
active ingredient
Prior art date
Application number
DK277372A
Other languages
Danish (da)
English (en)
Other versions
DK144306B (da
Inventor
S T Leslie
Original Assignee
Mundipharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mundipharma Ag filed Critical Mundipharma Ag
Publication of DK144306B publication Critical patent/DK144306B/da
Application granted granted Critical
Publication of DK144306C publication Critical patent/DK144306C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK277372A 1971-06-03 1972-06-02 Grundmasse til anvendelse ved fremstilling af en farmaceutiskenhedsdosis med langsom frigoerelse af en aktiv bestanddel samt fremgangsmaade til fremstilling deraf DK144306C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1883971A GB1405088A (en) 1971-06-03 1971-06-03 Slow release formulation
GB1883971 1971-06-03

Publications (2)

Publication Number Publication Date
DK144306B DK144306B (da) 1982-02-15
DK144306C true DK144306C (da) 1982-07-12

Family

ID=10119292

Family Applications (1)

Application Number Title Priority Date Filing Date
DK277372A DK144306C (da) 1971-06-03 1972-06-02 Grundmasse til anvendelse ved fremstilling af en farmaceutiskenhedsdosis med langsom frigoerelse af en aktiv bestanddel samt fremgangsmaade til fremstilling deraf

Country Status (18)

Country Link
US (1) US4235870A (fr)
JP (1) JPS569490B1 (fr)
AT (1) AT327390B (fr)
BE (1) BE783661A (fr)
CA (1) CA1009146A (fr)
CH (1) CH577830A5 (fr)
DE (1) DE2224534C3 (fr)
DK (1) DK144306C (fr)
ES (2) ES403435A1 (fr)
FI (1) FI55766C (fr)
FR (1) FR2140217B1 (fr)
GB (1) GB1405088A (fr)
IL (1) IL39430A (fr)
NL (1) NL174619C (fr)
NO (1) NO138683C (fr)
PH (2) PH12136A (fr)
SE (1) SE379636B (fr)
ZA (1) ZA723207B (fr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1488259A (en) * 1974-08-28 1977-10-12 Scherer Corp R P Method for increasing the bioavailability of digitalis cardiac glycosides
US4002718A (en) * 1974-10-16 1977-01-11 Arnar-Stone Laboratories, Inc. Gelatin-encapsulated digoxin solutions and method of preparing the same
US4076804A (en) * 1975-07-18 1978-02-28 Abbott Laboratories Erythromycin therapy
GB1593261A (en) 1976-07-23 1981-07-15 Inveresk Res Int Controlled release suppository
EP0013131A3 (fr) * 1978-12-27 1981-01-07 Mundipharma A.G. Composition pharmaceutique sous forme de dosage solide et procédé pour sa fabrication
IE49324B1 (en) * 1979-12-19 1985-09-18 Euro Celtique Sa Controlled release compositions
US4428925A (en) 1981-12-18 1984-01-31 Key Pharmaceuticals, Inc. Sustained release glycerol trinitrate
US4428926A (en) 1981-12-18 1984-01-31 Key Pharmaceuticals, Inc. Sustained release propranolol system
US4443428A (en) 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
US4432965A (en) * 1982-07-09 1984-02-21 Key Pharmaceuticals, Inc. Quinidine sustained release dosage formulation
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
GB8521350D0 (en) 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
US4734285A (en) * 1985-10-28 1988-03-29 The Dow Chemical Company Sustained release compositions
US4704285A (en) * 1985-11-18 1987-11-03 The Dow Chemical Company Sustained release compositions comprising hydroxypropyl cellulose ethers
GB2186485B (en) * 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
EP0249347B1 (fr) * 1986-06-10 1994-06-29 Euroceltique S.A. Composition à libération contrôlée de dihydrocodéine
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US4869908A (en) * 1987-01-09 1989-09-26 K.V. Pharmaceutical Co. Fibre formulations
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
BE1009257A3 (nl) * 1995-03-21 1997-01-07 Universiteit Gent Lab Voor Far Farmaceutische matrix.
US5811126A (en) * 1995-10-02 1998-09-22 Euro-Celtique, S.A. Controlled release matrix for pharmaceuticals
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US6780437B2 (en) 2001-10-23 2004-08-24 Upsher-Smith Laboratories, Inc. Coated potassium chloride granules and tablets
US20050226929A1 (en) * 2004-04-12 2005-10-13 Jianbo Xie Controlled release opioid analgesic formulation
GB0408308D0 (en) 2004-04-14 2004-05-19 Vectura Ltd Pharmaceutical compositions
DK1765292T3 (en) 2004-06-12 2018-01-02 Collegium Pharmaceutical Inc ABUSE PREVENTIONAL PHARMACEUTICAL FORMULATIONS
US20080260823A1 (en) * 2007-04-20 2008-10-23 Sciele Pharma, Inc. Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CA2991216C (fr) 2010-12-22 2020-04-28 Purdue Pharma L.P. Formes pharmaceutiques encapsulees, inviolables et a liberation controlee
ES2581323T3 (es) 2010-12-23 2016-09-05 Purdue Pharma Lp Formas de dosificación oral sólida resistentes a alteraciones
JP6279547B2 (ja) 2012-04-17 2018-02-14 パーデュー、ファーマ、リミテッド、パートナーシップ オピオイド誘発性有害薬力学的応答を治療するためのシステムおよび方法
BR112015017451B1 (pt) 2013-02-05 2023-01-10 Purdue Pharma L.P. Formulações farmacêuticas resistentes à violação
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US9849124B2 (en) 2014-10-17 2017-12-26 Purdue Pharma L.P. Systems and methods for treating an opioid-induced adverse pharmacodynamic response
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
DE1185336B (de) * 1961-12-14 1965-01-14 American Cyanamid Co Verfahren zur Herstellung von pharmazeutischen Praeparaten
NL273962A (fr) * 1962-01-25
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical

Also Published As

Publication number Publication date
SE379636B (fr) 1975-10-20
ZA723207B (en) 1973-03-28
NL174619B (nl) 1984-02-16
ATA457772A (de) 1975-04-15
CH577830A5 (fr) 1976-07-30
DE2224534B2 (de) 1977-10-20
US4235870A (en) 1980-11-25
FI55766C (fi) 1979-10-10
AT327390B (de) 1976-01-26
ES424533A1 (es) 1977-02-16
DK144306B (da) 1982-02-15
BE783661A (fr) 1972-09-18
NO138683C (no) 1978-10-25
NO138683B (no) 1978-07-17
CA1009146A (en) 1977-04-26
DE2224534C3 (de) 1981-04-02
JPS569490B1 (fr) 1981-03-02
FR2140217A1 (fr) 1973-01-12
NL174619C (nl) 1984-07-16
NL7207486A (fr) 1972-12-05
PH14809A (en) 1981-12-14
IL39430A (en) 1975-12-31
IL39430A0 (en) 1972-07-26
GB1405088A (en) 1975-09-03
DE2224534A1 (de) 1972-12-14
PH12136A (en) 1978-11-07
FI55766B (fi) 1979-06-29
ES403435A1 (es) 1975-05-01
FR2140217B1 (fr) 1976-03-12

Similar Documents

Publication Publication Date Title
DK144306C (da) Grundmasse til anvendelse ved fremstilling af en farmaceutiskenhedsdosis med langsom frigoerelse af en aktiv bestanddel samt fremgangsmaade til fremstilling deraf
DK132303C (da) Fremgangsmade til fremstilling af en legemiddelform med retarderende virkning
DK490178A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat i enhedsdosisform kapselpaefyldningsmaskine til anvendelse veat d fremgangsmaaden samt det fremstillede farmaceutiske praepar
CY578A (en) Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
BE776084A (fr) Injecteurs de medicament
MY7400329A (en) Drug for use in pharmaceutical composition
IT8050314A0 (it) Dispositivo per la somministrazione di medicamenti in polvere
ZA714095B (en) Bandage for administering drugs
CH516312A (de) Arneimittelgrundlage zur lokalen Anwendung therapeutischer Wirkstoffe
DK207575A (da) Legemiddel med psykotrop virkning dets anveldelse samt fremgangsmade til fremstilling deraf og af de aktive forbindelser deri
AR214234A1 (es) Dispositivo para la administracion de sustancias medicamentosas
FR2325387A1 (fr) Preparations antigeniques et medicament comprenant ces preparations
NO137899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider
IT983227B (it) Dispositivo oculare bioerodibile per la somministrazione continua controllata di una dose predeter minata di sostanza all occhio
BR7208420D0 (pt) Dispositivo farmaceutico solido
ZA71951B (en) Dosage units for the administration of medicaments and the like
NO801759L (no) Farmasoeytisk tilberedning for oral administrasjon samt fremgangsmaate for fremstilling av tilberedningen
GB1547562A (en) Guns eg for use in the administration of drugs or medicines to animals
DK144312C (da) Fremgangsmaade til fremstilling af et lactulosepulver til terapeutisk anvendelse
IT971938B (it) Compressa per uso medico chirur gico e simile
SE7510362L (sv) Antiarytmiska medel samt forfarande for framstellning derav
DK147695C (da) Fremgangsmaade til fremstilling af hoejt doserede tabletter af tetracyclin-derivater
SE381404B (sv) Apparat for att diagnosticera vissa typer av hjerttillstand hos en patient
BE787908A (fr) Medicament antidepressif et antiparkinsonien
NL151379B (nl) Werkwijze ter bereiding van een therapeutisch preparaat alsmede werkwijze ter bereiding van de daarbij te gebruiken actieve lincomycinederivaten.

Legal Events

Date Code Title Description
PUP Patent expired